Antihemophilic Factor (Recombinant) (Afstyla) and Methyl Aminolevulinate
Determining the interaction of Antihemophilic Factor (Recombinant) (Afstyla) and Methyl Aminolevulinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: methyl aminolevulinate topical
Brand name: Metvixia
Synonyms: Methyl aminolevulinate (topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Afstyla)-Methyl aminolevulinate topical
- Antihemophilic Factor (Recombinant) (Afstyla)-Methyl aminolevulinate Topical application
- Antihemophilic Factor (Recombinant) (Afstyla)-Methyl B-12 vitamin B12
- Antihemophilic Factor (Recombinant) (Afstyla)-Methyl Salicylate and Menthol Cream and Ointment
- Antihemophilic Factor (Recombinant) (Afstyla)-Methyl Salicylate and Menthol Lotion
- Antihemophilic Factor (Recombinant) (Afstyla)-Methyl salicylate topical
- Methyl Aminolevulinate-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Methyl Aminolevulinate-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Methyl Aminolevulinate-Antihemophilic Factor (Recombinant) (Nuwiq)
- Methyl Aminolevulinate-Antihemophilic Factor (Recombinant) (Recombinate)
- Methyl Aminolevulinate-Antihemophilic Factor (Recombinant) (Xyntha)
- Methyl Aminolevulinate-Antihemophilic factor (recombinant) pegylated-aucl Intravenous